Jens Bjørheim
Directeur Technique/Scientifique/R&D chez ULTIMOVACS ASA
Fortune : - $ au 30/06/2024
Profil
Jens Bjørheim is currently the Chief Medical Officer at Ultimovacs ASA. Previously, he worked as the Medical Director at Pronova BioPharma ASA from 2006 to 2008 and as the Senior Medical Director-Oncology at AstraZeneca A from 2013 to 2016.
He holds two doctorate degrees, one from the University of Oslo in 1999 and another from the same university in 2003.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ULTIMOVACS AS
-.--% | 31/12/2023 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Jens Bjørheim
| Sociétés | Poste | Début |
|---|---|---|
| ULTIMOVACS ASA | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Jens Bjørheim
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 01/01/2016 |
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Directeur Technique/Scientifique/R&D | 01/01/2008 |
Formation de Jens Bjørheim
| University of Oslo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ULTIMOVACS ASA | Health Technology |
| Entreprise privées | 2 |
|---|---|
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
